Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5 NR4a1 axis Nature Communications A phase 2 clinical trial has demonstrated that bimagrumab, when combined with semaglutide, resulted in significant weight loss for trial participants while maintaining lean muscle mass suggesting a promising approach for Diabetes mellitusProgress and opportunities in the evolving epidemic: Cell Precision obesity medicine: A phenotype guided framework for pharmacologic therapy across the lifespan Journal of Endocrinological Investigation Springer Nature Link